2009, Number 4
<< Back Next >>
Patol Rev Latinoam 2009; 47 (4)
Wegener’s granulomatosis type limitant (vasculitic). Finding in the autopsy of a boy
Jasso GGE, Salamanca GM, Gorráez MMT
Language: Spanish
References: 8
Page: 354-356
PDF size: 271.63 Kb.
Text Extraction
No abstract
REFERENCES
Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, et al. The epidemiology of Wegener granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87-92.
Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr 2004;163:425-34.
Hoffman GS, Kerr GS, Leavitt RY, HAllahan WC, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-499.
Travis WD. Pulmonary vaculitis. In: Leslie KO, Wick MR, editors. Practical pulmonary pathology. Philadelphia: Churchill Livingstone, 2005.
Reumatología Pediátrica 2008, 6: 13 doi: 10.1186/1546-0096- 6-13.
Hollander D, Manning RT. The use of alkylating agents in the treatment of Wegener's granulomatosis. Ann Intern Med 1967;67:393-8.
Fauci A, Wolff SM, Johnson JS. Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. N Engl J Med 1971;285(27):1493-6.
Lynch JP, White E, Tazelaar H, Langford CA. Wegener's granulomatosis: evolving concepts in treatment. Semin Respir Crit Care Med 2004;25(5):491-521.
Full text